Calcitriol - reference spectrum

Get a Price/Quote

MOQ : 1 Kilograms

Calcitriol - reference spectrum Specification

Molecular Weight
416.6 Grams (g)

Usage
Calcitriol is used to treat hyperparathyroidism (overactive parathyroid glands) and metabolic bone disease in people who have chronic kidney failure and are not receiving dialysis. Calcitriol is also used to treat calcium deficiency (hypocalcemia) and metabolic bone disease in people who are receiving dialysis.

Purity
98%

Melting Point
115 °C

Molecular Formula
C27H44O3

Calcitriol - reference spectrum Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Kilograms Per Month

Delivery Time
3-4 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Main Export Market(s)
Australia, Western Europe, Central America, Africa, Middle East, South America, Asia, Eastern Europe, North America

Main Domestic Market
All India

About Calcitriol - reference spectrum

Calcitriol - Reference Spectrum is a high-purity compound designed for precise analytical and medicinal applications. With a molecular weight of 416.6 g/mol and a purity of 98%, this compound is ideal for addressing calcium deficiency (hypocalcemia) and metabolic bone diseases. Its molecular formula, C27H44O3, contributes to its effectiveness in regulating calcium homeostasis. Calcitriol is widely utilized for treating hyperparathyroidism and metabolic bone diseases in individuals with chronic kidney failure, including those receiving or not receiving dialysis. The substance demonstrates a melting point of 115 C, ensuring stability under laboratory conditions. This product is tailored to meet the rigorous demands of researchers, healthcare professionals, and industries focused on advanced treatment solutions.

FAQs of Calcitriol - reference spectrum:

Q: What is Calcitriol used for?

A: Calcitriol is used to treat hyperparathyroidism, calcium deficiency, and metabolic bone diseases, particularly in individuals with chronic kidney failure, whether or not they are receiving dialysis.